Journal article

Adenosine monophosphate deaminase 3 activation shortens erythrocyte half-life and provides malaria resistance in mice

E Hortle, B Nijagal, DC Bauer, LM Jensen, SB Ahn, IA Cockburn, S Lampkin, D Tull, MJ McConville, BJ McMorran, SJ Foote, G Burgio

Blood | AMER SOC HEMATOLOGY | Published : 2016

Abstract

The factors that determine red blood cell (RBC) lifespan and the rate of RBC aging have not been fully elucidated. In several genetic conditions, including sickle cell disease, thalassemia, and G6PD deficiency, erythrocyte lifespan is significantly shortened. Many of these diseases are also associated with protection from severe malaria, suggesting a role for accelerated RBC senescence and clearance in malaria resistance. Here, we report a novel, N-ethyl-N-nitrosourea-induced mutation that causes a gain of function in adenosine 5′-monophosphate deaminase (AMPD3). Mice carrying the mutation exhibit rapid RBC turnover, with increased erythropoiesis, dramatically shortened RBC lifespan, and sig..

View full abstract

University of Melbourne Researchers

Grants

Awarded by Howard Hughes Medical Institute


Funding Acknowledgements

This work was supported by the National Health and Medical Research Council of Australia (program grant 490037 and project grants 605524 and APP1047090), the Australian Society for Parasitology, OzEMalaR, National Collaborative Research Infrastructure Strategy, the Education Investment Fund from the Department of Education and Training, the Australian Phenomics Network, the Howard Hughes Medical Institute, and the Bill and Melinda Gates Foundation.